Ceredex Value Advisors LLC Has $40.92 Million Stock Holdings in Revvity Inc. $RVTY

Key Points

• Ceredex Value Advisors LLC significantly reduced its stake in Revvity Inc. by 54.9%, now holding approximately 386,785 shares valued at $40.9 million after selling 471,108 shares in the past quarter.
• Analysts have lowered their ratings and target prices for Revvity, with JPMorgan and Goldman Sachs adjusting their targets from $120 to $100 and $140 to $125, respectively, indicating cautious outlooks on the stock.
• Revvity recently reported better-than-expected quarterly earnings, with an EPS of $1.18 compared to the consensus estimate of $1.14, alongside a dividend announcement of $0.07 per share to be paid in November.

Ceredex Value Advisors LLC cut its holdings in shares of Revvity Inc. (NYSE:RVTY - Free Report) by 54.9% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 386,785 shares of the company's stock after selling 471,108 shares during the period. Ceredex Value Advisors LLC owned 0.33% of Revvity worth $40,922,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently added to or reduced their stakes in RVTY. Raymond James Financial Inc. acquired a new position in Revvity during the 4th quarter valued at about $2,248,000. Mariner LLC lifted its position in Revvity by 9.8% during the 4th quarter. Mariner LLC now owns 7,746 shares of the company's stock valued at $865,000 after purchasing an additional 689 shares during the period. Marshall Wace LLP lifted its position in Revvity by 4.6% during the 4th quarter. Marshall Wace LLP now owns 3,556 shares of the company's stock valued at $397,000 after purchasing an additional 156 shares during the period. OneDigital Investment Advisors LLC acquired a new position in Revvity during the 4th quarter valued at about $220,000. Finally, Coldstream Capital Management Inc. lifted its position in Revvity by 6.4% during the 4th quarter. Coldstream Capital Management Inc. now owns 2,390 shares of the company's stock valued at $267,000 after purchasing an additional 143 shares during the period. 86.65% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on RVTY. Bank of America lowered their price target on Revvity from $116.00 to $110.00 and set a "buy" rating for the company in a research note on Thursday, June 26th. Stifel Nicolaus lowered their target price on Revvity from $120.00 to $110.00 and set a "hold" rating for the company in a research note on Tuesday, July 29th. Raymond James Financial reissued an "outperform" rating and set a $115.00 target price (down from $120.00) on shares of Revvity in a research note on Tuesday, July 29th. Wall Street Zen cut Revvity from a "buy" rating to a "hold" rating in a research note on Sunday, August 3rd. Finally, Evercore ISI decreased their price target on shares of Revvity from $116.00 to $115.00 and set an "outperform" rating for the company in a research note on Tuesday, July 8th. Ten analysts have rated the stock with a Buy rating and four have given a Hold rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $120.07.

Revvity Stock Up 1.1%

Shares of RVTY traded up $0.98 during mid-day trading on Friday, hitting $90.21. 786,177 shares of the company's stock were exchanged, compared to its average volume of 1,133,210. The company has a market cap of $10.47 billion, a PE ratio of 38.23, a P/E/G ratio of 2.42 and a beta of 0.91. The company has a debt-to-equity ratio of 0.43, a current ratio of 3.33 and a quick ratio of 2.75. Revvity Inc. has a 52 week low of $85.12 and a 52 week high of $129.50. The company has a 50-day simple moving average of $94.11 and a 200 day simple moving average of $98.02.

Revvity (NYSE:RVTY - Get Free Report) last released its quarterly earnings data on Monday, July 28th. The company reported $1.18 EPS for the quarter, beating the consensus estimate of $1.14 by $0.04. The company had revenue of $720.28 million during the quarter, compared to the consensus estimate of $711.26 million. Revvity had a return on equity of 7.66% and a net margin of 10.19%.The firm's revenue for the quarter was up 4.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.22 EPS. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS. On average, research analysts forecast that Revvity Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 7th. Stockholders of record on Friday, October 17th will be issued a $0.07 dividend. This represents a $0.28 annualized dividend and a dividend yield of 0.3%. The ex-dividend date of this dividend is Friday, October 17th. Revvity's dividend payout ratio is presently 11.86%.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.